Finasteride Use in Women

Contraindications and Precautions

• Women of childbearing age should not use finasteride due to severe teratogenic risk to male fetuses, but postmenopausal women may use it off-label for hair loss with careful consideration of limited efficacy data, as recommended by the American Academy of Dermatology 1
• The FDA recommends that patients should not donate blood until 6 months after the last dose due to risk to pregnant females, according to the FDA guidelines 2

Special Populations

• Finasteride may be suggested in select cases for adolescent female patients with hidradenitis suppurativa, particularly those with endocrine comorbidities like polycystic ovary syndrome, as suggested by the American Academy of Dermatology and the Endocrine Society 1, 3
• Careful assessment of benefits and risks is crucial in adolescent females with hidradenitis suppurativa, as recommended by the Endocrine Society 3, 4

Safety Considerations

• Sexual side effects may persist beyond drug discontinuation in some patients, according to Praxis Medical Insights 2

Finasteride for Women: Clinical Use and Contraindications

Clinical Indications in Women

• The American Academy of Family Physicians recommends finasteride as an effective antiandrogen for hirsutism in PCOS patients, but it should be combined with oral contraceptives rather than used as monotherapy 5
• Finasteride can be considered as an alternative antiandrogen when spironolactone is contraindicated or not tolerated, with a dose of 5 mg daily 5

Combination Therapy

• The American Academy of Family Physicians suggests that antiandrogens, such as finasteride, should always be combined with ovarian suppression (oral contraceptives) for optimal efficacy and contraception 5
• Combination therapy addresses both ovarian androgen production and peripheral androgen action, and must continue indefinitely unless underlying PCOS is corrected 5